University of Nebraska

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Nebraska sits in the top decile of US sponsors by registered trial count (#90 of 15,742 sponsors by registered trial count).

407 total trials 51 currently recruiting 261 completed early-phase tilt top decile by trial count

University of Nebraska: 407 sponsored US clinical trials, 51 recruiting.

University of Nebraska sponsors 407 registered US clinical trials on ClinicalTrials.gov, 51 of them currently recruiting, and 261 completed. 31 of these trials are in Phase 3-4 (later-stage) and 109 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Peripheral Arterial Disease, with 7 trials.

Top-decile sponsor footprint

University of Nebraska ranks in the top decile of sponsors by registered trial count (#90 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 36/100

261 of 332 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (78.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

407 total, page 5 of 9

COMPLETED Phase 4

Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery

NCT01669434
TERMINATED

Early Infancy Ureteral Reimplantation for Distal Ureteral Obstruction

NCT02419339
TERMINATED Phase 2

Docetaxel and Capecitabine With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

NCT02524275
COMPLETED Phase 3

Heartland Osteoporosis Prevention Study

NCT02186600
COMPLETED

The Effect of Sleeve Gastrectomy on Post-prandial Serum Bile Acids

NCT02302677
COMPLETED

Optimal Measurement of Thyroglobulin Measurement Following Thyroidectomy

NCT02347683
COMPLETED NA

The Effect of Light on the Fetal Biophysical Profile

NCT02453230
COMPLETED NA

Evaluation of the Distortion Correction Data Collection (DCDC) App Software

NCT02337647
COMPLETED NA

Influence of Exercise on the Mobility and Balance of Individuals With Multiple Sclerosis

NCT02524483
COMPLETED NA

The Use of Platelet Rich Fibrin in Pulpal and Periodontal Regeneration in Mature Teeth

NCT02477358
COMPLETED Phase 1

Pharmacokinetic Study of Intravitreal Aflibercept Injection in Eyes With Wet Age-related Macular Degeneration

NCT02204683
TERMINATED

Optimal Stent Selection for the Femoropopliteal Artery

NCT02602145
COMPLETED NA

Echo-guided Hemodynamic Management Strategy in Elderly Patients Undergoing Noncardiac Surgery

NCT01780727
TERMINATED

Comparison of Contrast Agents for MRI Perfusion Analysis in Brain Tumor Patients

NCT02095353
TERMINATED Phase 1

Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma

NCT02168270
COMPLETED

Bone Disease in Chronic Pancreatitis: A Complex Phenomenon

NCT02108509
COMPLETED

Speckle-tracking Tricuspid Annular Plane Systolic Excursion

NCT01968252
TERMINATED

Study of CMV in Kidney Transplant Recipients

NCT02061215
COMPLETED

Gonorrhea and Chlamydia HIV-infected Men Who Have Sex With Men

NCT02019771
COMPLETED

Comparison of Epidural and TAP Block in Abdominal Surgery

NCT01848951
TERMINATED NA

Effect of Disinfective Solution as an Adjunct to Maintenance Therapy of Inflamed Periodontal Pockets

NCT02316652
COMPLETED Phase 2

Prostaglandin Inhibition for Emphysema

NCT02006576
TERMINATED

Effect of Vascular Endothelial Growth Factor Blockers on Aqueous Humor Dynamics

NCT01994174
COMPLETED

EFV Pharmacokinetics & Pharmacogenomics in Older HIV-infected Patients

NCT01886404
COMPLETED NA

Self-management Adherence in Heart Failure Patients

NCT01964053
COMPLETED NA

Home Based Care Transitions Tailored by Cognition and Patient Activation

NCT02045147
COMPLETED NA

Treatment of Vitamin D Deficiency in Intestinal Rehabilitation Clinic Patients With a Portable Ultraviolet B Lamp

NCT01930539
COMPLETED NA

The Effect of Exercise on Strength and Mobility and Corresponding CNS Plasticity in Multiple Sclerosis Patients

NCT01816100
COMPLETED Phase 2

Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer

NCT01959672
COMPLETED Phase 1

Leukine (Sargramostim) for Parkinson's Disease

NCT01882010
TERMINATED

Mathematical Modeling to Determine Basic Muscle Properties in the Failing Heart

NCT01778894
COMPLETED

Aqueous Humor Dynamics and Biometric Parameters in Eyes of Children

NCT01290588
COMPLETED Phase 4

Platelet Inhibition in Patients With Systolic Heart Failure

NCT01765400
TERMINATED Phase 1

Cardiac Allograft Remodeling and Effects of Sirolimus

NCT01889992
COMPLETED Phase 1

ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer

NCT01825603
COMPLETED

Sjogren-Larsson Syndrome: Natural History, Clinical Variation and Evaluation of Biochemical Markers

NCT01971957
COMPLETED NA

Care4U: Self Management Intervention for Older Adult Caregivers

NCT01764399
COMPLETED NA

Smokers' Response to Nicotine Dependence Genotyping

NCT01780038
COMPLETED NA

Feasibility of a Touch Screen Computer Based Breast-feeding Educational Support Program

NCT03308058
COMPLETED Phase 4

Local Minocycline to Reduce Future Inflammation and Bone Loss in Periodontal Maintenance Patients

NCT01647282
COMPLETED

Detection of Staph Colonization in Pre-op Arthroplasty Patients

NCT01648088
COMPLETED

Leptin Levels in Papillary Thyroid Cancer

NCT01659385
COMPLETED Phase 3

Regadenoson Real Time Perfusion Imaging Trial-Optison

NCT01489176
TERMINATED NA

Nurse PIV Insertion Success With and Without Assistive Devices in Patients 0-12 Months of Age

NCT01637987
COMPLETED NA

The Effect of a Liquid Protein Modular on Growth and Outcomes in the NICU

NCT01609868
COMPLETED

Long-term Outcome of Laparoscopic Hiatal Hernia Repair With or Without Alloderm Mesh at a University Hospital

NCT01776827
COMPLETED

First-Sight Refractive Error Correction in the Developing World

NCT01598818
COMPLETED Phase 1

Inhaled Milrinone Use in Patients Receiving HeartMate II LVAD: A Pilot Study

NCT01571037
COMPLETED NA

Weight Maintenance Through Physical Activity and Social Support in Rural Middle-Aged Women

NCT01487538
COMPLETED NA

HEART Camp: Promoting Adherence to Exercise in Patients With Heart Failure

NCT01658670
← Previous Page 5 of 9 Next →

Phase Distribution

PhaseTrial count
Phase 1 57
Phase 2 52
Phase 3 10
Phase 4 21

Therapeutic Areas

Peripheral Arterial Disease 7
Lymphoma 6
Breast Cancer 5
Rheumatoid Arthritis 5
Peripheral Artery Disease 3
Multiple Myeloma 3
Healthy 3
Sleep Fragmentation 2
Graft-versus-host Disease (GVHD) 2
Parkinson's Disease 2

What is open in the University of Nebraska pipeline

51 recruiting of 407 indexed (13% open); 261 completed (64%).

Phase mix: 31 late (III/IV) vs 109 early (I/II) (early-phase heavy).

Top condition: Peripheral Arterial Disease (7 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Nebraska: open-pipeline peers nationwide

Peers matched on 407 registered trials and 13% open enrollment, not the therapeutic-area sidebar.

University of Nebraska sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0100200300400500 10%15%20%25% Total trials Recruiting share University of NebraskaCase Comprehensive Cancer CenterTakedaUniversity of Kansas Medical CenterSt. Jude Children's Research HospitalAddario Lung Cancer Medical InstituteAmerican UniversityAnnexonAnsun Biopharma
University of Nebraska sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Nebraska sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 407 trials (± recruiting share)

Sponsors near 13% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this University of Nebraska page

407 registered trials is a research-attention snapshot, not an endorsement of University of Nebraska or any single study.

  • 51 of University of Nebraska's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Peripheral Arterial Disease is the condition University of Nebraska studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Peripheral Arterial Disease trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Nebraska pipeline card: 407 registered trials from official public datasets.Report a data error.